United States · FDA National Drug Code directory
Rizatriptan Benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-865_6ace7fac-e700-4a32-95ce-07ffbd0201ea
- Product NDC
- 69097-865
- Form
- TABLET
- Composition / generic term
- Rizatriptan Benzoate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160722
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BLISTER PACK (69097-865-17) · 69097-865-17
- 3 TABLET in 1 CARTON (69097-865-85) · 69097-865-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →